Clinical Trials Browser

Phase 1/2 × Cushing Syndrome × 30 days × Clear all

NCT05804669 2026-06-04

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Phase 1/2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion